欧洲32国近期抵达移民疫苗接种策略差异调查
2017年3月至5月,欧盟/欧洲经济区32国及瑞士的每位国家疫苗接种专家完成电子问卷(应答率100%)。虽然28国报告有国家层面接种指南,但仅6国针对近期抵达移民有专门指南且实施不一致;成人移民补种接种水平低,仅13国提供MMR、10国收费。
要点
- 30国对无接种证据的移民儿童按国家免疫规划重新接种,所有国家均接种百白破和脊灰,31国接种MMR,25国接种乙肝。
- 成人移民补种接种水平低,仅13国提供MMR,10国收费。
核心结论
- 现有指南常非移民特异性且可能未在实践中应用,需明确应接种哪些疫苗。
- 需要专门针对成人移民补种接种的策略。
- 应在多场所免费提供接种,并为一线医务人员提供充分指导和培训。
研究设计与样本
- 2017年3月至5月,欧盟/欧洲经济区每国及瑞士的一位国家疫苗接种专家完成电子问卷(应答率100%)。
- 采用描述性分析计算百分比,框架分析综合自由文本回答。
主要发现
- 28位专家报告有国家层面接种指南,但仅6国针对近期抵达移民有专门指南且实施不一致。
- 多数专家建议在入境点(n=13)或收容层面(接待中心、移民营地、拘留中心)(n=21)提供多种接种机会。
- 30国对无既往接种证据的移民儿童按国家免疫规划重新接种。
- 成人移民补种接种水平低,仅13国提供MMR,10国收费。
关键数值与推荐
- 移民儿童接种:所有国家均接种百白破和脊灰,31国接种MMR,25国接种乙肝。
- 成人移民:仅13国提供MMR补种,10国收费。
临床怎么用
- 在入境健康检查、入境点或收容层面等多场所为移民提供疫苗接种机会。
- 对无接种证据的移民儿童按国家免疫规划重新接种。
- 为一线医务人员提供充分指导和培训以实施移民接种。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundMigrants within the European Union and European Economic Area (EU/EEA) may be underimmunised and lack documentation on previous vaccinations. We investigated approaches to vaccination in recently arrived adult and child migrants, and guideline availability and implementation. Methods: Between March and May 2017, a national vaccination expert from every EU/EEA country and Switzerland completed an electronic questionnaire. We used descriptive analyses to calculate percentages, and framework analysis to synthesise free-text responses. Results: We approached 32 countries (response rate 100%). Although 28 experts reported vaccination guidance at national level, specific guidelines for recently arrived migrants were only available in six countries and not consistently implemented. Twenty-three countries administered vaccinations during on-arrival health checks. Most experts recommended multiple vaccination opportunities be made available: at point of entry (n = 13) or at holding level (reception centres, migrant camps, detention centres) (n = 21). In 30 countries, child migrants without evidence of previous vaccination were re-vaccinated according to the national schedule. Diphtheria-pertussis-tetanus and polio vaccinations were given to migrant children in all countries, measles-mumps-rubella (MMR) in 31 countries, hepatitis B vaccination in 25. Low levels of catch-up vaccination were reported in adult migrants, with only 13 countries offering MMR and 10 countries charging fees. Conclusion: Existing guidance is often not migrant-specific and may not be applied in practice; clarification is needed on which vaccines should be given. Strategies are needed specifically for catch-up vaccination in adult migrants. Vaccinations should be offered in multiple settings, free of charge, with sufficient guidance and training provided to front-line healthcare professionals.
引用
- Hargreaves S, Nellums LB, Ravensbergen SJ, et al. Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017. Euro Surveill. 2018. PMID: 30326996. doi:10.2807/1560-7917.ES.2018.23.41.1700772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。